Goldman Sachs raises Enterprise Products stock price target on higher commodity prices

Enterprise Products beat Q4 2025 estimates with EPS $0.75 vs $0.69 (8.7% surprise) and revenue $13.79B vs $12.37B (11.48% surprise); Goldman raised its Q1 2026 EBITDA estimate to $2,655m (from $2,567m) and lifted its price target to $37 from $34 while keeping a Neutral rating. UBS reiterated a Buy and highlighted ~60% of post-dividend free cash flow goes to buybacks; Stifel raised its PT to $41. Goldman flagged a modest Q1 headwind from octane maintenance but expects stronger Q2, and noted focus on 2027 activity vs management's ~$11.3B EBITDA target; stock trades at $37.45 near a 52-week high ($38.22) and has returned 20.9% over six months.

Analysis

Enterprise’s reported beat and analyst upgrades mask a crisp, two-part earnings sensitivity: durable fee-based cashflow plus a high-volatility marketing bucket tied to NGL/LPG spreads and Waha differentials. That marketing bucket can swing quarterly EBITDA by a mid-to-high single-digit percent and will dominate quarter-to-quarter headlines until export logistics and U.S. production trends settle.

Second-order winners include export infrastructure owners (terminal operators, long-haul barges and tankers) and logistics contractors — tighter export flows lift utilization and service pricing even if commodity prices subsequently mean-revert. Conversely, refiners and domestic petchem plants are the marginal demand source; sustained weak global demand would depress NGL cracks and quickly reverse the current tailwind.

Key catalysts and timing: near-term (days–weeks) focus on management commentary in the mid-April fundamentals deck and any updates to 2027 activity assumptions; medium-term (1–3 months) watch for Q2 EBITDA inflection once octane units return from maintenance; longer-term (12–24 months) the realized 2027 EBITDA and buyback cadence will determine multiple expansion. Tail risks include a sharp petchem demand pullback or a rerouting of flows if Gulf export capacity bottlenecks force basis resets.

Consensus appears to prize headline EBITDA upside while under-acknowledging the modest buyback support and non-linear marketing volatility — that creates an asymmetric payoff where upside requires delivery on both commodity levels and structural activity assumptions for 2027, not just a one-quarter beat.

Key Decisions for Investors

• Initiate a core long EPD (6–12 month horizon): buy a 3–5% position size to play the Q2 operational rebound and continued export demand. Target 20–30% upside if 2027 activity assumptions hold; set tactical stop-loss at -12% to protect against rapid marketing mean-reversion or a petchem demand shock.
• Pair trade — long EPD / short a smaller midstream with higher marketing exposure (e.g., TRGP) (3–9 months): 1:1 notional to capture relative resilience from scale and export optionality. Expect 10–25% relative outperformance if EPD’s export and fee-based mix re-rates; limit loss to 8% on the pair if both names gap down on macro risk-off.
• Options play to buy the Q2 re-rate (3–9 months): buy a diagonal call spread on EPD (buy 12–18 month OTM calls, sell 3–6 month nearer-term calls) to capture upside when octane units return while financing theta. Reward scenario: 2x–4x payoff if commodity levels and management guidance surprise higher; max loss = premium paid (size to risk no more than 1% of book).
• Event hedge / catalyst watch (days–weeks): reduce gross exposure or buy short-dated put protection ahead of the mid-April fundamentals deck if management provides conservative 2027 activity assumptions or signals materially reduced buybacks. Cost of insurance justified if the deck increases uncertainty around the marketing contribution or capital return cadence.